Keep An Eye On Nicox, OPK Gets FDA Nod, PBMD Abuzz, RDHL On The Move

Shares of Prima BioMed Ltd. (PBMD) were up over 10% in extended trading on Tuesday, following encouraging initial safety data from the first cohort of patients in its phase IIb clinical study of IMP321.

from RTT - Biotech http://ift.tt/28PUigO
via IFTTT